Article Text

PDF

Prolonged azathioprine treatment of non-remitting multiple sclerosis
  1. J. A. Rosen
  1. Presbyterian-University Hospital, Pittsburgh, USA
  2. Westmoreland Hospital, Greensburg, Pennsylvania, USA

    Abstract

    Two groups of 85 and 42 ambulatory patients with moderately advanced non-remitting multiple sclerosis were treated for six to 14 and three to six years with daily azathioprine. Less than 10% of these patients became confined to a wheelchair. This far exceeds any possible result in a group of non-remitting multiple sclerosis patients not so treated.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.